Herbaux, C., Bret, C., Bachy, E., Bories, P., Di Blasi, R., Cuffel, A., Gastinne, T., Lamy, T., Roussel, M., Bouabdallah, K., Beauvais, D., Cartron, G., Bay, J.-O., Blaise, D., Rubio, M.-T., Mohty, M., Le Bras, F., Casasnovas, O., Guy, J., Guidez, S., Llorente, C. C., Hermine, O., La Rochelle, L. D., Carras, S., Guffroy, B., Caillat-Zucman, S., Houot, R. and Le Gouill, S. (2020) “Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.284786.